David Schaffer, Ph.D. is 4DMT co-founder and has served as our Chief Scientific Advisor and a member of our board of directors since the company’s inception in 2013 through early 2022. Dr. Schaffer has served as a Professor of Chemical and Biomolecular Engineering, Bioengineering, Molecular and Cell Biology, as well as the Director of California Institute for Quantitative Biosciences (QB3) at U.C. Berkeley, and Deputy Director of the Bakar Labs at the Bakar BioEnginuity Hub. He received a B.S. in Chemical Engineering from Stanford University in 1993 and earned his Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology in 1998.